Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOC2017217 Eye Drops in Early Senile Cataract
CTR20213389Phase 2Completed
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZOC2017217 in senile cataract (ARC), sponsored by Zhongshan Ophthalmic Center. Started Jan 2022; status: completed.
02
Drugs
ZOC2017217
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on CTR20213389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213389.